Table 3.
Retroperitoneal lymph node dissection and ejaculatory function in survivors of testicular cancer
| Authors Year of study report | Patients who received RPLND (N) | P‐RPLND or PC‐RPLND | Dissection template and/or nerve‐sparing | Patients (N) | Patients with normal ejaculation (N) (%) |
|---|---|---|---|---|---|
|
Coogan et al.62
1996 |
81 | PC‐RPLND | Nerve‐sparing | 81 | 62 (77) |
|
Jacobsen et al.63
1999 |
174 | PC‐RPLND | Modified bilateral template | 89 | 10 (11) |
| Unilateral template | 29 | 22 (76) | |||
| Nerve‐sparing | 56 | 50 (89) | |||
|
Heidenreich et al.64
2003 |
239 | P‐RPLND | Nerve‐sparing (88% unilaterally and 12% bilaterally) | 239 | 223 (93) |
|
Heidenreich et al.65
2009 |
152 | PC‐RPLND | Modified template | 98 | N/A (85) |
| Full bilateral template | 54 | N/A (25) | |||
|
Pettus et al.66
2009 |
136 | PC‐RPLND | Nerve‐sparing and bilateral template | 136 | 107 (79) |
|
Subramanian et al.67
2010 |
208 | P‐RPLND vs PC‐RPLND | P‐RPLND | 70 | 60 (81) |
| PC‐RPLND | 54 | 22 (41) | |||
|
Beck et al.68
2010 |
176 | P‐RPLND | Nerve‐sparing | 135 | 134 (99) |
| Non‐nerve‐sparing | 37 | 33 (89) |
N/A, not available; P‐RPLND, primary RPLND; PC‐RPLND, postchemotherapy RPLND; RPLND, retroperitoneal lymph node dissection.